6-Aminocaproic acid (EACA) is a monoamino carboxylic acid that acts as a potent and orally active inhibitor of plasmin and plasminogen. It functions as an antifibrinolytic agent, preventing clot lysis by competitively binding to lysine residues on plasminogen, which inhibits plasmin formation and reduces fibrinolysis. This product is suitable for research into bleeding disorders, metabolic diseases, and cancer, and is also classified as an endogenous metabolite.
- Potent and orally active inhibitor of plasmin and plasminogen
- Acts as an antifibrinolytic agent
- Prevents clot lysis through competitive binding to plasminogen
- Reduces fibrinolysis
- Useful for research into bleeding disorders
- Targets PAI-1 and PROTAC linkers
- Applicable in metabolic disease and cancer research
- Classified as an endogenous metabolite